U.S. flag

An official website of the United States government

NM_144997.7(FLCN):c.1300+2T>G AND Birt-Hogg-Dube syndrome

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Sep 3, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV005090932.1

Allele description [Variation Report for NM_144997.7(FLCN):c.1300+2T>G]

NM_144997.7(FLCN):c.1300+2T>G

Gene:
FLCN:folliculin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17p11.2
Genomic location:
Preferred name:
NM_144997.7(FLCN):c.1300+2T>G
HGVS:
  • NC_000017.11:g.17216378A>C
  • NG_008001.2:g.25811T>G
  • NM_001353229.2:c.1354+2T>G
  • NM_001353230.2:c.1300+2T>G
  • NM_001353231.2:c.1300+2T>G
  • NM_144997.7:c.1300+2T>GMANE SELECT
  • LRG_325t1:c.1300+2T>G
  • LRG_325:g.25811T>G
  • NC_000017.10:g.17119692A>C
  • NM_144997.5:c.1300+2T>G
Links:
dbSNP: rs1064793766
NCBI 1000 Genomes Browser:
rs1064793766
Molecular consequence:
  • NM_001353229.2:c.1354+2T>G - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001353230.2:c.1300+2T>G - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001353231.2:c.1300+2T>G - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_144997.7:c.1300+2T>G - splice donor variant - [Sequence Ontology: SO:0001575]

Condition(s)

Name:
Birt-Hogg-Dube syndrome
Synonyms:
Birt Hogg Dubé syndrome
Identifiers:
MONDO: MONDO:0800444; MedGen: C0346010; Orphanet: 122; OMIM: PS135150

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV005765944Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Sep 3, 2024)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Splicing in action: assessing disease causing sequence changes.

Baralle D, Baralle M.

J Med Genet. 2005 Oct;42(10):737-48. Review.

PubMed [citation]
PMID:
16199547
PMCID:
PMC1735933

Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dubé syndrome.

Schmidt LS, Nickerson ML, Warren MB, Glenn GM, Toro JR, Merino MJ, Turner ML, Choyke PL, Sharma N, Peterson J, Morrison P, Maher ER, Walther MM, Zbar B, Linehan WM.

Am J Hum Genet. 2005 Jun;76(6):1023-33. Epub 2005 Apr 25.

PubMed [citation]
PMID:
15852235
PMCID:
PMC1196440
See all PubMed Citations (5)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV005765944.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

This sequence change affects a donor splice site in intron 11 of the FLCN gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in FLCN are known to be pathogenic (PMID: 15852235). This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individual(s) with clinical features of Birt–Hogg–Dube ́ syndrome (PMID: 20618353, 37490463). ClinVar contains an entry for this variant (Variation ID: 419280). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 16, 2025